Literature DB >> 29769187

Intraoperative intraluminal injection of N-acetylcysteine allowing treatment of distal intestinal obstruction syndrome without the need for enterotomy.

Nicholas Js Chilvers1, James Wheeler1.   

Abstract

We describe a case of an 18-year-old man who suffers from cystic fibrosis and developed distal intestinal obstruction syndrome while being treated as an inpatient. Following failed medical management, we proceeded to laparotomy where the small bowel was decompressed with retrograde milking into the stomach, leaving a section of impacted stool in the distal ileum. N-acetylcysteine was injected into the bowel lumen proximal to the obstruction. This resulted in dissolution of the stool without the need for enterotomy and is, to our knowledge, the first successful example of this technique in the literature. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cystic fibrosis; drug therapy related to surgery; gastrointestinal surgery; general surgery

Mesh:

Substances:

Year:  2018        PMID: 29769187      PMCID: PMC5965749          DOI: 10.1136/bcr-2017-223965

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Treatment of resistant distal intestinal obstruction syndrome with a modified antegrade continence enema procedure.

Authors:  I J Clifton; A M Morton; N S Ambrose; D G Peckham; S P Conway
Journal:  J Cyst Fibros       Date:  2004-12       Impact factor: 5.482

2.  Intestinal obstruction after lung transplantation in children with cystic fibrosis.

Authors:  R K Minkes; J C Langer; M A Skinner; R P Foglia; A O'Hagan; A H Cohen; G B Mallory; C B Huddleston; E N Mendeloff
Journal:  J Pediatr Surg       Date:  1999-10       Impact factor: 2.545

Review 3.  Question 8: How should distal intestinal obstruction syndrome [DIOS] be managed?

Authors:  Tyler Groves; Andrea Kench; Shoma Dutt; Kevin Gaskin; Dominic A Fitzgerald
Journal:  Paediatr Respir Rev       Date:  2016-04-28       Impact factor: 2.726

4.  The age-related incidence of meconium ileus equivalent in a cystic fibrosis population: the impact of high-energy intake.

Authors:  H O Andersen; K Hjelt; E Waever; K Overgaard
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-10       Impact factor: 2.839

Review 5.  Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients.

Authors:  Carla Colombo; Helmut Ellemunter; Roderick Houwen; Anne Munck; Chris Taylor; Michael Wilschanski
Journal:  J Cyst Fibros       Date:  2011-06       Impact factor: 5.482

6.  A technique for the surgical treatment of distal intestinal obstructive syndrome by hand-assisted laparoscopy.

Authors:  Travis Abicht; Christian Jones; Garrett Coyan; Steven Stites; Michael Moncure
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-06       Impact factor: 1.719

7.  Gastrointestinal surgery in cystic fibrosis: a 20-year review.

Authors:  Paul J Farrelly; Caroline Charlesworth; Sophie Lee; Kevin W Southern; Colin T Baillie
Journal:  J Pediatr Surg       Date:  2013-11-18       Impact factor: 2.545

8.  Distal intestinal obstruction syndrome in cystic fibrosis: presentation, outcome and management in a tertiary hospital (2007-2012).

Authors:  Rami Subhi; Rachel Ooi; Felicity Finlayson; Tom Kotsimbos; John Wilson; Wei Ran Lee; Roger Wale; Satish Warrier
Journal:  ANZ J Surg       Date:  2013-11-18       Impact factor: 1.872

9.  Distal intestinal obstructive syndrome in adults with cystic fibrosis: a surgical perspective.

Authors:  Karen Speck; Anthony Charles
Journal:  Arch Surg       Date:  2008-06

10.  Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS.

Authors:  Roderick H Houwen; Hubert P van der Doef; Isabelle Sermet; Anne Munck; Bruno Hauser; Jaroslaw Walkowiak; Eddy Robberecht; Carla Colombo; Maarten Sinaasappel; Michael Wilschanski
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-01       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.